Dermatologicals in Ecuador

Dermatologicals in Ecuador

There has been a drive to promote and educate about vaginal antifungals and this is leading to increased value sales. The two key players in the segment, Bayer, with Gynocanesten, and Genommalab, with Lomecan V, have invested in advertising campaigns to eliminate the taboos associated with vaginal issues and to promote awareness and empower women to seek treatment without embarrassment. These advertising campaigns educate about the causes, symptoms, and available solutions for vaginal fungal inf...

Euromonitor International's Dermatologicals in Ecuador report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.